News

April 01, 2024

Principal Investigator Interview: RTOG 3521 Study of Combination Toripalimab and Chemotherapy in Recurrent Metastatic Nasopharyngeal Cancer

Read more
See More News
April 01, 2024

Principal Investigator Interview: The ‘KEYSTROKE’ RTOG 3507 Study of Pembrolizumab plus Stereotactic Re-Irradiation for Recurrent Head and Neck Cancer

Read more
image

Principal Investigator Interview: RTOG 3521

Combination Toripalimab and Chemotherapy in Recurrent Metastatic Nasopharyngeal Cancer

Read more

About RTOG Foundation

The RTOG Foundation is a nonprofit organization dedicated to improving outcomes for cancer patients through the conduct of practice changing clinical trials. RTOG collaborates with partners from industry and federally funded programs to support its research.

Read about RTOG
image
image

Partners

There are several ways you can participate in RTOG Foundation as either a member site, an industry collaborator, or by enrolling in one of our studies.

Partners

Participate in RTOG Research

To participate as an RTOG study investigator, your organization must be part of the RTOG Foundation network. Patients who wish to participate in a study must be under the care of an RTOG participating investigator. For additional information, email info@rtog.org or call 1-215-574-3173.

See our clinical trials